Outcomes of an extended Morrow procedure without a concomitant mitral valve procedure for hypertrophic obstructive cardiomyopathy
The indications for a concomitant mitral valve (MV) procedure remain controversial for patients with hypertrophic obstructive cardiomyopathy (HOCM). According to previous studies, a concomitant MV surgery was required in 11–20% of inpatient operations. Thus, we aimed to study the outcomes of an exte...
Gespeichert in:
| Veröffentlicht in: | Scientific reports 2016-06, Vol.6 (1), p.29031-29031, Article 29031 |
|---|---|
| Hauptverfasser: | , , , , , , , , |
| Format: | Artikel |
| Sprache: | eng |
| Schlagworte: | |
| Online-Zugang: | Volltext |
| Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
| container_end_page | 29031 |
|---|---|
| container_issue | 1 |
| container_start_page | 29031 |
| container_title | Scientific reports |
| container_volume | 6 |
| creator | Liu, Yun Song, Yunhu Gao, Ge Ran, Jun Su, Wenjun Li, Haojie Tang, Yajie Duan, Fujian Sun, Hansong |
| description | The indications for a concomitant mitral valve (MV) procedure remain controversial for patients with hypertrophic obstructive cardiomyopathy (HOCM). According to previous studies, a concomitant MV surgery was required in 11–20% of inpatient operations. Thus, we aimed to study the outcomes of an extended Morrow procedure without a concomitant MV procedure for HOCM patients who had no intrinsic abnormalities of the MV apparatus. We retrospectively reviewed 232 consecutive HOCM patients who underwent extended Morrow procedures from January 2010 to October 2014. Only 10 (4.31%) patients with intrinsic MV diseases underwent concomitant MV procedures. Of the 232 patients, 230 had no to mild mitral regurgitation (MR) postoperatively. We separated the 232 patients into two groups according to preoperative MR degree. One group is mild MR and the other is moderate or severe MR. The three-month, one-year and three-year composite end-point event-free survival rates had no difference between two groups (p = 0.820). When we separated the patients to postoperative no or trace MR group and mild MR group, there was also no difference on survival rates (p = 0.830). In conclusion, concomitant mitral valve procedures are not necessary for HOCM patients with MR caused by systolic anterior motion, even moderate to severe extent. |
| doi_str_mv | 10.1038/srep29031 |
| format | Article |
| fullrecord | <record><control><sourceid>proquest_pubme</sourceid><recordid>TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_4928185</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>1801437349</sourcerecordid><originalsourceid>FETCH-LOGICAL-c438t-49c94672cd2e686525449c091b77b36d37a950cb05655b10e24f43f7fd42d3c33</originalsourceid><addsrcrecordid>eNplkU9rFTEUxYMotrRd-AUk4EaFV_N3MtkIpbQqVLrRdcgkmU7KTDImmVffst-8ebz6eGo2N9z7y7knHADeYHSOEW0_5eRmIhHFL8AxQYyvCCXk5cH9CJzlfI_q4UQyLF-DIyIoF20jjsHj7VJMnFyGsYc6QPe7uGCdhd9jSvEBzikaZ5fk4IMvQ1wK1NDEUJ_4okOBtSQ9wrUe1-4A7mOCw2Z2qaQ4D97A2OWSFlN8xYxO1sdpE2ddhs0peNXrMbuz53oCfl5f_bj8urq5_fLt8uJmZRhty4pJI1kjiLHENW3DCWe1hSTuhOhoY6nQkiPTId5w3mHkCOsZ7UVvGbHUUHoCPu9056WbnDUubJ2rOflJp42K2qu_J8EP6i6uFZOkxS2vAu-fBVL8tbhc1OSzceOog4tLVrhFmFFBmazou3_Q-7ikUL-3pVpKuSRbRx92lEkx1xj7vRmM1DZbtc-2sm8P3e_JP0lW4OMOyHUU7lw6WPmf2hMVNbEP</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>1808335923</pqid></control><display><type>article</type><title>Outcomes of an extended Morrow procedure without a concomitant mitral valve procedure for hypertrophic obstructive cardiomyopathy</title><source>MEDLINE</source><source>DOAJ Directory of Open Access Journals</source><source>Springer Nature OA Free Journals</source><source>Nature Free</source><source>EZB-FREE-00999 freely available EZB journals</source><source>PubMed Central</source><source>Free Full-Text Journals in Chemistry</source><creator>Liu, Yun ; Song, Yunhu ; Gao, Ge ; Ran, Jun ; Su, Wenjun ; Li, Haojie ; Tang, Yajie ; Duan, Fujian ; Sun, Hansong</creator><creatorcontrib>Liu, Yun ; Song, Yunhu ; Gao, Ge ; Ran, Jun ; Su, Wenjun ; Li, Haojie ; Tang, Yajie ; Duan, Fujian ; Sun, Hansong</creatorcontrib><description>The indications for a concomitant mitral valve (MV) procedure remain controversial for patients with hypertrophic obstructive cardiomyopathy (HOCM). According to previous studies, a concomitant MV surgery was required in 11–20% of inpatient operations. Thus, we aimed to study the outcomes of an extended Morrow procedure without a concomitant MV procedure for HOCM patients who had no intrinsic abnormalities of the MV apparatus. We retrospectively reviewed 232 consecutive HOCM patients who underwent extended Morrow procedures from January 2010 to October 2014. Only 10 (4.31%) patients with intrinsic MV diseases underwent concomitant MV procedures. Of the 232 patients, 230 had no to mild mitral regurgitation (MR) postoperatively. We separated the 232 patients into two groups according to preoperative MR degree. One group is mild MR and the other is moderate or severe MR. The three-month, one-year and three-year composite end-point event-free survival rates had no difference between two groups (p = 0.820). When we separated the patients to postoperative no or trace MR group and mild MR group, there was also no difference on survival rates (p = 0.830). In conclusion, concomitant mitral valve procedures are not necessary for HOCM patients with MR caused by systolic anterior motion, even moderate to severe extent.</description><identifier>ISSN: 2045-2322</identifier><identifier>EISSN: 2045-2322</identifier><identifier>DOI: 10.1038/srep29031</identifier><identifier>PMID: 27357867</identifier><language>eng</language><publisher>London: Nature Publishing Group UK</publisher><subject>692/4019/592/75/74/1540 ; 692/700/565/545 ; Ablation ; Adult ; Cardiomyopathy ; Cardiomyopathy, Hypertrophic - complications ; Cardiomyopathy, Hypertrophic - drug therapy ; Cardiomyopathy, Hypertrophic - surgery ; Cardiovascular Agents - therapeutic use ; China ; Combined Modality Therapy ; Disease-Free Survival ; Electrocardiography ; Female ; Follow-Up Studies ; Heart Septum - surgery ; Hospitals ; Humanities and Social Sciences ; Humans ; Iatrogenesis ; Male ; Medical prognosis ; Middle Aged ; Mitral Valve - surgery ; Mitral Valve Insufficiency - surgery ; multidisciplinary ; Patients ; Proportional Hazards Models ; Retrospective Studies ; Science ; Surgery ; Survival ; Treatment Outcome ; Ventricular Outflow Obstruction - etiology ; Ventricular Outflow Obstruction - surgery</subject><ispartof>Scientific reports, 2016-06, Vol.6 (1), p.29031-29031, Article 29031</ispartof><rights>The Author(s) 2016</rights><rights>Copyright Nature Publishing Group Jun 2016</rights><rights>Copyright © 2016, Macmillan Publishers Limited 2016 Macmillan Publishers Limited</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c438t-49c94672cd2e686525449c091b77b36d37a950cb05655b10e24f43f7fd42d3c33</citedby><cites>FETCH-LOGICAL-c438t-49c94672cd2e686525449c091b77b36d37a950cb05655b10e24f43f7fd42d3c33</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC4928185/pdf/$$EPDF$$P50$$Gpubmedcentral$$Hfree_for_read</linktopdf><linktohtml>$$Uhttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC4928185/$$EHTML$$P50$$Gpubmedcentral$$Hfree_for_read</linktohtml><link.rule.ids>230,314,727,780,784,864,885,27924,27925,41120,42189,51576,53791,53793</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/27357867$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Liu, Yun</creatorcontrib><creatorcontrib>Song, Yunhu</creatorcontrib><creatorcontrib>Gao, Ge</creatorcontrib><creatorcontrib>Ran, Jun</creatorcontrib><creatorcontrib>Su, Wenjun</creatorcontrib><creatorcontrib>Li, Haojie</creatorcontrib><creatorcontrib>Tang, Yajie</creatorcontrib><creatorcontrib>Duan, Fujian</creatorcontrib><creatorcontrib>Sun, Hansong</creatorcontrib><title>Outcomes of an extended Morrow procedure without a concomitant mitral valve procedure for hypertrophic obstructive cardiomyopathy</title><title>Scientific reports</title><addtitle>Sci Rep</addtitle><addtitle>Sci Rep</addtitle><description>The indications for a concomitant mitral valve (MV) procedure remain controversial for patients with hypertrophic obstructive cardiomyopathy (HOCM). According to previous studies, a concomitant MV surgery was required in 11–20% of inpatient operations. Thus, we aimed to study the outcomes of an extended Morrow procedure without a concomitant MV procedure for HOCM patients who had no intrinsic abnormalities of the MV apparatus. We retrospectively reviewed 232 consecutive HOCM patients who underwent extended Morrow procedures from January 2010 to October 2014. Only 10 (4.31%) patients with intrinsic MV diseases underwent concomitant MV procedures. Of the 232 patients, 230 had no to mild mitral regurgitation (MR) postoperatively. We separated the 232 patients into two groups according to preoperative MR degree. One group is mild MR and the other is moderate or severe MR. The three-month, one-year and three-year composite end-point event-free survival rates had no difference between two groups (p = 0.820). When we separated the patients to postoperative no or trace MR group and mild MR group, there was also no difference on survival rates (p = 0.830). In conclusion, concomitant mitral valve procedures are not necessary for HOCM patients with MR caused by systolic anterior motion, even moderate to severe extent.</description><subject>692/4019/592/75/74/1540</subject><subject>692/700/565/545</subject><subject>Ablation</subject><subject>Adult</subject><subject>Cardiomyopathy</subject><subject>Cardiomyopathy, Hypertrophic - complications</subject><subject>Cardiomyopathy, Hypertrophic - drug therapy</subject><subject>Cardiomyopathy, Hypertrophic - surgery</subject><subject>Cardiovascular Agents - therapeutic use</subject><subject>China</subject><subject>Combined Modality Therapy</subject><subject>Disease-Free Survival</subject><subject>Electrocardiography</subject><subject>Female</subject><subject>Follow-Up Studies</subject><subject>Heart Septum - surgery</subject><subject>Hospitals</subject><subject>Humanities and Social Sciences</subject><subject>Humans</subject><subject>Iatrogenesis</subject><subject>Male</subject><subject>Medical prognosis</subject><subject>Middle Aged</subject><subject>Mitral Valve - surgery</subject><subject>Mitral Valve Insufficiency - surgery</subject><subject>multidisciplinary</subject><subject>Patients</subject><subject>Proportional Hazards Models</subject><subject>Retrospective Studies</subject><subject>Science</subject><subject>Surgery</subject><subject>Survival</subject><subject>Treatment Outcome</subject><subject>Ventricular Outflow Obstruction - etiology</subject><subject>Ventricular Outflow Obstruction - surgery</subject><issn>2045-2322</issn><issn>2045-2322</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2016</creationdate><recordtype>article</recordtype><sourceid>C6C</sourceid><sourceid>EIF</sourceid><sourceid>ABUWG</sourceid><sourceid>AFKRA</sourceid><sourceid>AZQEC</sourceid><sourceid>BENPR</sourceid><sourceid>CCPQU</sourceid><sourceid>DWQXO</sourceid><sourceid>GNUQQ</sourceid><recordid>eNplkU9rFTEUxYMotrRd-AUk4EaFV_N3MtkIpbQqVLrRdcgkmU7KTDImmVffst-8ebz6eGo2N9z7y7knHADeYHSOEW0_5eRmIhHFL8AxQYyvCCXk5cH9CJzlfI_q4UQyLF-DIyIoF20jjsHj7VJMnFyGsYc6QPe7uGCdhd9jSvEBzikaZ5fk4IMvQ1wK1NDEUJ_4okOBtSQ9wrUe1-4A7mOCw2Z2qaQ4D97A2OWSFlN8xYxO1sdpE2ddhs0peNXrMbuz53oCfl5f_bj8urq5_fLt8uJmZRhty4pJI1kjiLHENW3DCWe1hSTuhOhoY6nQkiPTId5w3mHkCOsZ7UVvGbHUUHoCPu9056WbnDUubJ2rOflJp42K2qu_J8EP6i6uFZOkxS2vAu-fBVL8tbhc1OSzceOog4tLVrhFmFFBmazou3_Q-7ikUL-3pVpKuSRbRx92lEkx1xj7vRmM1DZbtc-2sm8P3e_JP0lW4OMOyHUU7lw6WPmf2hMVNbEP</recordid><startdate>20160630</startdate><enddate>20160630</enddate><creator>Liu, Yun</creator><creator>Song, Yunhu</creator><creator>Gao, Ge</creator><creator>Ran, Jun</creator><creator>Su, Wenjun</creator><creator>Li, Haojie</creator><creator>Tang, Yajie</creator><creator>Duan, Fujian</creator><creator>Sun, Hansong</creator><general>Nature Publishing Group UK</general><general>Nature Publishing Group</general><scope>C6C</scope><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>3V.</scope><scope>7X7</scope><scope>7XB</scope><scope>88A</scope><scope>88E</scope><scope>88I</scope><scope>8FE</scope><scope>8FH</scope><scope>8FI</scope><scope>8FJ</scope><scope>8FK</scope><scope>ABUWG</scope><scope>AFKRA</scope><scope>AZQEC</scope><scope>BBNVY</scope><scope>BENPR</scope><scope>BHPHI</scope><scope>CCPQU</scope><scope>DWQXO</scope><scope>FYUFA</scope><scope>GHDGH</scope><scope>GNUQQ</scope><scope>HCIFZ</scope><scope>K9.</scope><scope>LK8</scope><scope>M0S</scope><scope>M1P</scope><scope>M2P</scope><scope>M7P</scope><scope>PIMPY</scope><scope>PQEST</scope><scope>PQQKQ</scope><scope>PQUKI</scope><scope>Q9U</scope><scope>7X8</scope><scope>5PM</scope></search><sort><creationdate>20160630</creationdate><title>Outcomes of an extended Morrow procedure without a concomitant mitral valve procedure for hypertrophic obstructive cardiomyopathy</title><author>Liu, Yun ; Song, Yunhu ; Gao, Ge ; Ran, Jun ; Su, Wenjun ; Li, Haojie ; Tang, Yajie ; Duan, Fujian ; Sun, Hansong</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c438t-49c94672cd2e686525449c091b77b36d37a950cb05655b10e24f43f7fd42d3c33</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2016</creationdate><topic>692/4019/592/75/74/1540</topic><topic>692/700/565/545</topic><topic>Ablation</topic><topic>Adult</topic><topic>Cardiomyopathy</topic><topic>Cardiomyopathy, Hypertrophic - complications</topic><topic>Cardiomyopathy, Hypertrophic - drug therapy</topic><topic>Cardiomyopathy, Hypertrophic - surgery</topic><topic>Cardiovascular Agents - therapeutic use</topic><topic>China</topic><topic>Combined Modality Therapy</topic><topic>Disease-Free Survival</topic><topic>Electrocardiography</topic><topic>Female</topic><topic>Follow-Up Studies</topic><topic>Heart Septum - surgery</topic><topic>Hospitals</topic><topic>Humanities and Social Sciences</topic><topic>Humans</topic><topic>Iatrogenesis</topic><topic>Male</topic><topic>Medical prognosis</topic><topic>Middle Aged</topic><topic>Mitral Valve - surgery</topic><topic>Mitral Valve Insufficiency - surgery</topic><topic>multidisciplinary</topic><topic>Patients</topic><topic>Proportional Hazards Models</topic><topic>Retrospective Studies</topic><topic>Science</topic><topic>Surgery</topic><topic>Survival</topic><topic>Treatment Outcome</topic><topic>Ventricular Outflow Obstruction - etiology</topic><topic>Ventricular Outflow Obstruction - surgery</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Liu, Yun</creatorcontrib><creatorcontrib>Song, Yunhu</creatorcontrib><creatorcontrib>Gao, Ge</creatorcontrib><creatorcontrib>Ran, Jun</creatorcontrib><creatorcontrib>Su, Wenjun</creatorcontrib><creatorcontrib>Li, Haojie</creatorcontrib><creatorcontrib>Tang, Yajie</creatorcontrib><creatorcontrib>Duan, Fujian</creatorcontrib><creatorcontrib>Sun, Hansong</creatorcontrib><collection>Springer Nature OA Free Journals</collection><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>ProQuest Central (Corporate)</collection><collection>Health & Medical Collection</collection><collection>ProQuest Central (purchase pre-March 2016)</collection><collection>Biology Database (Alumni Edition)</collection><collection>Medical Database (Alumni Edition)</collection><collection>Science Database (Alumni Edition)</collection><collection>ProQuest SciTech Collection</collection><collection>ProQuest Natural Science Collection</collection><collection>Hospital Premium Collection</collection><collection>Hospital Premium Collection (Alumni Edition)</collection><collection>ProQuest Central (Alumni) (purchase pre-March 2016)</collection><collection>ProQuest Central (Alumni Edition)</collection><collection>ProQuest Central UK/Ireland</collection><collection>ProQuest Central Essentials</collection><collection>Biological Science Collection</collection><collection>ProQuest Central</collection><collection>Natural Science Collection</collection><collection>ProQuest One Community College</collection><collection>ProQuest Central Korea</collection><collection>Health Research Premium Collection</collection><collection>Health Research Premium Collection (Alumni)</collection><collection>ProQuest Central Student</collection><collection>SciTech Premium Collection</collection><collection>ProQuest Health & Medical Complete (Alumni)</collection><collection>ProQuest Biological Science Collection</collection><collection>Health & Medical Collection (Alumni Edition)</collection><collection>Medical Database</collection><collection>Science Database</collection><collection>Biological Science Database</collection><collection>Access via ProQuest (Open Access)</collection><collection>ProQuest One Academic Eastern Edition (DO NOT USE)</collection><collection>ProQuest One Academic</collection><collection>ProQuest One Academic UKI Edition</collection><collection>ProQuest Central Basic</collection><collection>MEDLINE - Academic</collection><collection>PubMed Central (Full Participant titles)</collection><jtitle>Scientific reports</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Liu, Yun</au><au>Song, Yunhu</au><au>Gao, Ge</au><au>Ran, Jun</au><au>Su, Wenjun</au><au>Li, Haojie</au><au>Tang, Yajie</au><au>Duan, Fujian</au><au>Sun, Hansong</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Outcomes of an extended Morrow procedure without a concomitant mitral valve procedure for hypertrophic obstructive cardiomyopathy</atitle><jtitle>Scientific reports</jtitle><stitle>Sci Rep</stitle><addtitle>Sci Rep</addtitle><date>2016-06-30</date><risdate>2016</risdate><volume>6</volume><issue>1</issue><spage>29031</spage><epage>29031</epage><pages>29031-29031</pages><artnum>29031</artnum><issn>2045-2322</issn><eissn>2045-2322</eissn><abstract>The indications for a concomitant mitral valve (MV) procedure remain controversial for patients with hypertrophic obstructive cardiomyopathy (HOCM). According to previous studies, a concomitant MV surgery was required in 11–20% of inpatient operations. Thus, we aimed to study the outcomes of an extended Morrow procedure without a concomitant MV procedure for HOCM patients who had no intrinsic abnormalities of the MV apparatus. We retrospectively reviewed 232 consecutive HOCM patients who underwent extended Morrow procedures from January 2010 to October 2014. Only 10 (4.31%) patients with intrinsic MV diseases underwent concomitant MV procedures. Of the 232 patients, 230 had no to mild mitral regurgitation (MR) postoperatively. We separated the 232 patients into two groups according to preoperative MR degree. One group is mild MR and the other is moderate or severe MR. The three-month, one-year and three-year composite end-point event-free survival rates had no difference between two groups (p = 0.820). When we separated the patients to postoperative no or trace MR group and mild MR group, there was also no difference on survival rates (p = 0.830). In conclusion, concomitant mitral valve procedures are not necessary for HOCM patients with MR caused by systolic anterior motion, even moderate to severe extent.</abstract><cop>London</cop><pub>Nature Publishing Group UK</pub><pmid>27357867</pmid><doi>10.1038/srep29031</doi><tpages>1</tpages><oa>free_for_read</oa></addata></record> |
| fulltext | fulltext |
| identifier | ISSN: 2045-2322 |
| ispartof | Scientific reports, 2016-06, Vol.6 (1), p.29031-29031, Article 29031 |
| issn | 2045-2322 2045-2322 |
| language | eng |
| recordid | cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_4928185 |
| source | MEDLINE; DOAJ Directory of Open Access Journals; Springer Nature OA Free Journals; Nature Free; EZB-FREE-00999 freely available EZB journals; PubMed Central; Free Full-Text Journals in Chemistry |
| subjects | 692/4019/592/75/74/1540 692/700/565/545 Ablation Adult Cardiomyopathy Cardiomyopathy, Hypertrophic - complications Cardiomyopathy, Hypertrophic - drug therapy Cardiomyopathy, Hypertrophic - surgery Cardiovascular Agents - therapeutic use China Combined Modality Therapy Disease-Free Survival Electrocardiography Female Follow-Up Studies Heart Septum - surgery Hospitals Humanities and Social Sciences Humans Iatrogenesis Male Medical prognosis Middle Aged Mitral Valve - surgery Mitral Valve Insufficiency - surgery multidisciplinary Patients Proportional Hazards Models Retrospective Studies Science Surgery Survival Treatment Outcome Ventricular Outflow Obstruction - etiology Ventricular Outflow Obstruction - surgery |
| title | Outcomes of an extended Morrow procedure without a concomitant mitral valve procedure for hypertrophic obstructive cardiomyopathy |
| url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2024-12-20T07%3A04%3A01IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_pubme&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Outcomes%20of%20an%20extended%20Morrow%20procedure%20without%20a%20concomitant%20mitral%20valve%20procedure%20for%20hypertrophic%20obstructive%20cardiomyopathy&rft.jtitle=Scientific%20reports&rft.au=Liu,%20Yun&rft.date=2016-06-30&rft.volume=6&rft.issue=1&rft.spage=29031&rft.epage=29031&rft.pages=29031-29031&rft.artnum=29031&rft.issn=2045-2322&rft.eissn=2045-2322&rft_id=info:doi/10.1038/srep29031&rft_dat=%3Cproquest_pubme%3E1801437349%3C/proquest_pubme%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=1808335923&rft_id=info:pmid/27357867&rfr_iscdi=true |